Stryker Corporation (SYK)

NYQ – Real Time Price. Currency in USD

332.71

+16.60 (5.25%)

At close: Jun 26, 2026, 4:05 PM EDT

330.35

-2.36 (-0.71%)

After-hours: Jun 26, 2026, 7:45 PM EDT

12.06.2026

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now

Stryker faces cyberattack fallout, but strong procedure demand, record Mako adoption and global expansion continue to support long-term growth.

04.06.2026

Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures

SYK launches TPX HD, a small bone power tool built for complex revisions, MIS and oral maxillofacial cases with higher torque and speed.

03.06.2026

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?

02.06.2026

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

PORTAGE, Mich., June 2, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support performance, control and ergonomics in a wide range of challenging orthopaedic procedures such as total joint revisions, minimally invasive surgery and oral maxillofacial procedures.

27.05.2026

Stryker Launches Pangea Plating System in Europe for Fracture Fixation

SYK launches Pangea Plating System in Europe, completing its first London case as it broadens trauma care solutions for many fractures.

26.05.2026

Stryker Launches Pangea Plating System and Completes First Case in Europe

AMSTERDAM--(BUSINESS WIRE)--Stryker announced the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns.

19.05.2026

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

CHARLEVOIX, Mich.--(BUSINESS WIRE)--BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, Stryker (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in.

Videos

No Data

There is no data to display

Press releases

02.06.2026

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

26.05.2026

Stryker Launches Pangea Plating System and Completes First Case in Europe

AMSTERDAM--(BUSINESS WIRE)--Stryker announced the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns.

19.05.2026

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

18.05.2026

AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study

BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, today announced the enrollment of the first patient in its first-in-human (FIH) study for Pulsatile Intravascular Lithotripsy (PIVL) therapy in a coronary indication. The POWER CAD I study will evaluate the feasibility of the Pulse IVL™ System for the treatment of patients with moderate to severely calcified coronary arteri.

Stryker Corporation (SYK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Stryker Corporation (SYK)

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now

Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Stryker Launches Pangea Plating System in Europe for Fracture Fixation

Stryker Launches Pangea Plating System and Completes First Case in Europe

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

Videos

No Data

Press releases

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Stryker Launches Pangea Plating System and Completes First Case in Europe

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now

Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Stryker Launches Pangea Plating System in Europe for Fracture Fixation

Stryker Launches Pangea Plating System and Completes First Case in Europe

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

Videos

No Data

Press releases

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Stryker Launches Pangea Plating System and Completes First Case in Europe

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study

Search stocks

Stryker Corporation (SYK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Stryker Corporation (SYK)

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now

Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Stryker Launches Pangea Plating System in Europe for Fracture Fixation

Stryker Launches Pangea Plating System and Completes First Case in Europe

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

Videos

No Data

Press releases

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Stryker Launches Pangea Plating System and Completes First Case in Europe

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now

Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Stryker Launches Pangea Plating System in Europe for Fracture Fixation

Stryker Launches Pangea Plating System and Completes First Case in Europe

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

Videos

No Data

Press releases

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Stryker Launches Pangea Plating System and Completes First Case in Europe

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study